AAAAAA

   
Results: 1-3 |
Results: 3
ANTAGONISM OF THE GPIIB IIIA RECEPTOR WITH THE NONPEPTIDIC MOLECULE BIBU52 - INHIBITION OF PLATELET-AGGREGATION IN-VITRO AND ANTITHROMBOTICEFFICACY IN-VIVO/
Authors: GUTH BD SEEWALDTBECKER E HIMMELSBACH F WEISENBERGER H MULLER TH
Citation: Bd. Guth et al., ANTAGONISM OF THE GPIIB IIIA RECEPTOR WITH THE NONPEPTIDIC MOLECULE BIBU52 - INHIBITION OF PLATELET-AGGREGATION IN-VITRO AND ANTITHROMBOTICEFFICACY IN-VIVO/, Journal of cardiovascular pharmacology, 30(2), 1997, pp. 261-272
DESIGN OF HIGHLY POTENT NONPEPTIDIC FIBRINOGEN RECEPTOR ANTAGONISTS
Authors: HIMMELSBACH F AUSTEL V GUTH B LINZ G MULLER TH PIEPER H SEEWALDTBECKER E WEISENBERGER H
Citation: F. Himmelsbach et al., DESIGN OF HIGHLY POTENT NONPEPTIDIC FIBRINOGEN RECEPTOR ANTAGONISTS, European journal of medicinal chemistry, 30, 1995, pp. 243-254
THE NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST BIBU-52, IN CONTRAST TOASPIRIN, DOES NOT INTERFERE WITH THE MODULATION OF THROMBUS FORMATIONBY VASCULAR CELLS
Authors: MULLER TH RUHR K HIMMELSBACH F SEEWALDTBECKER E
Citation: Th. Muller et al., THE NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST BIBU-52, IN CONTRAST TOASPIRIN, DOES NOT INTERFERE WITH THE MODULATION OF THROMBUS FORMATIONBY VASCULAR CELLS, Thrombosis and haemostasis, 69(6), 1993, pp. 1072-1072
Risultati: 1-3 |